300583 Stock Overview
Researches and develops new steroid biomedicine intermediates.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Shandong Sito Bio-technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥12.15 |
| 52 Week High | CN¥23.84 |
| 52 Week Low | CN¥11.51 |
| Beta | 0.17 |
| 11 Month Change | -3.57% |
| 3 Month Change | -19.48% |
| 1 Year Change | -26.06% |
| 33 Year Change | -14.47% |
| 5 Year Change | -39.33% |
| Change since IPO | -66.49% |
Recent News & Updates
Why We're Not Concerned Yet About Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 26% Share Price Plunge
Jun 06
There May Be Reason For Hope In Shandong Sito Bio-technology's (SZSE:300583) Disappointing Earnings
May 05Risks Still Elevated At These Prices As Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) Shares Dive 30%
Apr 16Recent updates
Why We're Not Concerned Yet About Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 26% Share Price Plunge
Jun 06There May Be Reason For Hope In Shandong Sito Bio-technology's (SZSE:300583) Disappointing Earnings
May 05Risks Still Elevated At These Prices As Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) Shares Dive 30%
Apr 16Shareholder Returns
| 300583 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.6% | 1.0% | -1.4% |
| 1Y | -26.1% | -15.1% | -18.4% |
Return vs Industry: 300583 underperformed the CN Pharmaceuticals industry which returned -15.1% over the past year.
Return vs Market: 300583 underperformed the CN Market which returned -18.4% over the past year.
Price Volatility
| 300583 volatility | |
|---|---|
| 300583 Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300583's share price has been volatile over the past 3 months.
Volatility Over Time: 300583's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 1,200 | Lianbiao Jin | www.sitobiotech.com |
Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid biomedicine intermediates. Its products include 9a-hydroxyandrostenedione, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tetraene, androstenedione, ketal, 3-ketal, norandrostenedione, and betamethasone epoxy hydrolyzate, as well as 1,4-androstenedione. The company was founded in 2002 and is based in Heze, China.
Shandong Sito Bio-technology Co., Ltd. Fundamentals Summary
| 300583 fundamental statistics | |
|---|---|
| Market cap | CN¥2.30b |
| Earnings (TTM) | CN¥33.32m |
| Revenue (TTM) | CN¥1.19b |
69.2x
P/E Ratio1.9x
P/S RatioIs 300583 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300583 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.19b |
| Cost of Revenue | CN¥940.49m |
| Gross Profit | CN¥248.90m |
| Other Expenses | CN¥215.59m |
| Earnings | CN¥33.32m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 27, 2024
| Earnings per share (EPS) | 0.18 |
| Gross Margin | 20.93% |
| Net Profit Margin | 2.80% |
| Debt/Equity Ratio | 41.6% |
How did 300583 perform over the long term?
See historical performance and comparison